Stock Expert AI
Equity research screen

Thermo Fisher Scientific (TMO) Stock Forecast 2026

This page provides a consensus forecast for Thermo Fisher Scientific (TMO) extending to 2026. The information presented is for educational purposes only and does not constitute financial advice. Forecasts are inherently speculative and should be contextualized with independent research and an awareness of current market conditions.

This page provides a stock forecast for Thermo Fisher Scientific (TMO) extending to 2026. The forecast integrates expert analysis with available financial data to project potential stock performance. As a major player in the Healthcare sector, TMO's stock outlook is influenced by sector trends, technological advancements, and economic factors.
Stocks12Screens50Average score72.75UpdatedDaily
Data sources: Financial Modeling Prep | Yahoo Finance | SEC Filings 70,000+ securities analyzed

Thermo Fisher Scientific (TMO) Forecast Overview

This forecast focuses on the projected stock performance of Thermo Fisher Scientific (TMO) through 2026. As a major player in the Healthcare sector, TMO's stock outlook is influenced by industry trends, technological advancements, and broader economic factors. This analysis aims to provide a balanced view, acknowledging both potential opportunities and inherent risks.

Names rising to the top of the screen

The strongest names remain easy to scan without losing the valuation context behind the ranking.

1
TMO Thermo Fisher Scientific Inc.
$532.48 -1.97% $197.9B Healthcare
43Score
 2
SNDX Syndax Pharmaceuticals, Inc.
$22.80 +0.40% $2.0B Healthcare
79Score
 3
ANAB AnaptysBio, Inc.
$58.00 +7.11% $2.5B Healthcare
79Score
 4
XFOR X4 Pharmaceuticals, Inc.
$3.82 -0.26% $360M Healthcare
76Score
 5
CGEN Compugen Ltd.
$2.37 +1.72% $224M Healthcare
76Score
 6
ABVX Abivax S.A.
$136.65 -0.81% $10.0B Healthcare
76Score
 7
ABCL AbCellera Biologics Inc.
$6.46 +4.95% $2.0B Healthcare
76Score
 8
KRRO Korro Bio, Inc.
$12.25 -0.24% $122M Healthcare
75Score
 9
NVAX Novavax, Inc.
$7.92 -3.53% $1.4B Healthcare
74Score
 10
CAMP CAMP4 Therapeutics Corporation
$3.71 -4.87% $79M Healthcare
73Score
 11
NUVB Nuvation Bio Inc.
$5.80 +2.84% $2.0B Healthcare
73Score
 12
DCTH Delcath Systems, Inc.
$12.81 -0.31% $442M Healthcare
73Score

Where valuation pressure is clustering

Healthcare100%

Key Considerations for TMO in 2026

Thermo Fisher Scientific's performance is closely tied to healthcare spending, research and development investments, and its ability to innovate. Keep in mind that unforeseen events and market corrections can significantly impact stock valuations. This page should be used for informational purposes only.

Questions worth resolving before acting on the screen

What factors could affect Thermo Fisher Scientific's stock price in 2026?

Market sentiment, industry-specific trends, and company-specific news can all influence the stock price. Broader economic conditions and geopolitical events may also have an impact.

How reliable are stock forecasts?

Stock forecasts are speculative and not guaranteed. They represent a snapshot of expert opinions at a specific point in time and are subject to change.

Where can I find more information about Thermo Fisher Scientific?

Refer to Thermo Fisher Scientific's investor relations page, financial news outlets, and regulatory filings for additional information.

What is the Healthcare sector's outlook?

The Healthcare sector is influenced by factors such as regulatory changes, technological advancements, and demographic shifts. Conduct thorough research to understand the sector's dynamics.

Explore More Research

Stock Expert AI provides data and analysis tools for educational purposes. This is not financial advice. Past performance does not guarantee future results. Always consult a qualified financial advisor before making investment decisions. Data sources: Financial Modeling Prep, Yahoo Finance.